Turn Therapeutics Inc.
TTRX
$5.25
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 55.25% | 100.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.03% | 74.81% | |||
| Operating Income | -56.03% | -74.81% | |||
| Income Before Tax | -58.11% | -58.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -58.11% | -58.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.11% | -58.55% | |||
| EBIT | -56.03% | -74.81% | |||
| EBITDA | -56.85% | -76.65% | |||
| EPS Basic | -56.60% | -58.24% | |||
| Normalized Basic EPS | -56.67% | -57.89% | |||
| EPS Diluted | -56.60% | -58.24% | |||
| Normalized Diluted EPS | -56.67% | -57.89% | |||
| Average Basic Shares Outstanding | 1.04% | 0.04% | |||
| Average Diluted Shares Outstanding | 1.04% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||